At the conclusion of this application-based activity, participants will be able to:
  • Analyze the changing paradigm in clinical approaches to management of B-cell malignancies with BTK therapy and the implications for patient care.
  • Examine key issues in therapy selection, including appropriate sequencing and combination of agents in a range of clinical scenarios based on individual patient factors, as well as disease and treatment status.
  • Identify strategies to successfully incorporate novel therapies for B-cell malignancies, including the growing range of targeted therapies, into clinical practice.